Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on hepatocellular carcinoma: Pathologists’ review
Tony El Jabbour, Stephen M. Lagana, Hwajeong Lee
World Journal of Gastroenterology (2019) Vol. 25, Iss. 14, pp. 1653-1665
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
Bufu Tang, Jinyu Zhu, Jie Li, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 175
Combined hepatocellular-cholangiocarcinoma: An update
Aurélie Beaufrère, Julien Caldéraro, Valérie Paradis
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1212-1224
Open Access | Times Cited: 148
Systemic treatment of HCC in special populations
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 4, pp. 931-943
Open Access | Times Cited: 102
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Stefania Cannito, Umberto Dianzani, Maurizio Parola, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 19
Pathologic and molecular features of hepatocellular carcinoma: An update
Mukul Vij, Julien Caldéraro
World Journal of Hepatology (2021) Vol. 13, Iss. 4, pp. 393-410
Open Access | Times Cited: 37
The therapeutic landscape of hepatocellular carcinoma
Suchira Gallage, María García‐Beccaria, Marta Szydlowska, et al.
Med (2021) Vol. 2, Iss. 5, pp. 505-552
Open Access | Times Cited: 37
Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
Joon Hyuk Choi, Jae Y. Ro
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1826-1826
Open Access | Times Cited: 19
A Prospective Phase II Study Evaluating Intraoperative Electrochemotherapy of Hepatocellular Carcinoma
Mihajlo Djokić, Maja Čemažar, Maša Bošnjak, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3778-3778
Open Access | Times Cited: 28
PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting DDX3X to stabilize Rab27a mRNA in hepatocellular carcinoma
Zhilei Zhang, Ye Zhou, Yuming Jia, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism
Hua-guo Feng, Chuan-Xin Wu, Guo‐Chao Zhong, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15879-15898
Closed Access | Times Cited: 10
Clinicopathological Study on Morphological Subtypes of Hepatocellular Carcinoma: A Single Tertiary Referral Center Experience
Christine Saler, Shijin Shuai, Jan Beckervordersandforth, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Hepatocellular carcinoma: Morphological spectrum and subtyping as per the World Health Organization classification on FNA biopsy with cell block samples
Bhawana Dhiman, Reetu Kundu, Suvradeep Mitra, et al.
Cancer Cytopathology (2025) Vol. 133, Iss. 4
Closed Access
Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint
Neşe Karadağ Soylu
Journal of Gastrointestinal Cancer (2020) Vol. 51, Iss. 4, pp. 1176-1186
Closed Access | Times Cited: 27
EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells
Natalia Pediconi, Debora Salerno, Leonardo Lupacchini, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 7
Open Access | Times Cited: 26
Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
Chengbin Guo, Yuqin Tang, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways
Yun Li, Hui Xiong
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Long non‐coding RNA GAS5 overexpression inhibits M2‐like polarization of tumour‐associated macrophages in SMCC‐7721 cells by promoting PTEN expression
Xun Wang, F Li, Wei Zhao, et al.
International Journal of Experimental Pathology (2020) Vol. 101, Iss. 6, pp. 215-222
Open Access | Times Cited: 21
Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology‐Pathology Correlation
Hernan R. Bello, Zaid Mahdi, Shu Kwun Lui, et al.
Journal of Magnetic Resonance Imaging (2021) Vol. 55, Iss. 3, pp. 681-697
Closed Access | Times Cited: 19
Astragalus polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages
Chun Li, Xin-You Pan, Mingyun Ma, et al.
Pharmaceutical Biology (2021) Vol. 59, Iss. 1, pp. 1531-1537
Open Access | Times Cited: 18
MRI features associated with HCC histologic subtypes: a western American and European bicenter study
Sébastien Mulé, Ali Serhal, Athena Galletto Pregliasco, et al.
European Radiology (2022) Vol. 33, Iss. 2, pp. 1342-1352
Closed Access | Times Cited: 14
Sevoflurane suppresses hepatocellular carcinoma cell progression via circ_0001649/miR-19a-3p/SGTB axis.
Nai Sun, Jianzhuang Gong, Wei Zhang, et al.
PubMed (2023) Vol. 38, Iss. 5, pp. 537-547
Closed Access | Times Cited: 8
Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
Anastasia Murtha-Lemekhova, Daniel Hornuß, Georgios Polychronidis, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
Saleh A. Alqahtani, Faisal M Sanai, Ashwaq Alolayan, et al.
Saudi Journal of Gastroenterology (2020) Vol. 26, Iss. 7, pp. 1-1
Open Access | Times Cited: 19
Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
Takahiro Kodama, Tetsuo Takehara
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 147-158
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top